These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 29680336)

  • 21. Tissue mapping by cardiac magnetic resonance imaging for the prognostication of cardiac amyloidosis: A systematic review and meta-analysis.
    Cai S; Haghbayan H; Chan KKW; Deva DP; Jimenez-Juan L; Connelly KA; Ng MY; Yan RT; Yan AT
    Int J Cardiol; 2024 May; 403():131892. PubMed ID: 38382853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement.
    Treibel TA; Fontana M; Gilbertson JA; Castelletti S; White SK; Scully PR; Roberts N; Hutt DF; Rowczenio DM; Whelan CJ; Ashworth MA; Gillmore JD; Hawkins PN; Moon JC
    Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27511979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of tissue Doppler-derived Tei index and two-dimensional speckle tracking imaging derived longitudinal strain on predicting outcome of patients with light-chain cardiac amyloidosis.
    Liu D; Hu K; Herrmann S; Cikes M; Ertl G; Weidemann F; Störk S; Nordbeck P
    Int J Cardiovasc Imaging; 2017 Jun; 33(6):837-845. PubMed ID: 28265790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial function and geometry differences in transthyretin versus immunoglobulin light chain amyloidosis: a cardiac magnetic resonance study.
    Palmer C; Truong VT; Slivnick JA; Wolking S; Coleman P; Mazur W; Zareba KM
    Sci Rep; 2022 Jan; 12(1):140. PubMed ID: 34996915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac Magnetic Resonance T
    Duca F; Kammerlander AA; Panzenböck A; Binder C; Aschauer S; Loewe C; Agis H; Kain R; Hengstenberg C; Bonderman D; Mascherbauer J
    JACC Cardiovasc Imaging; 2018 Dec; 11(12):1924-1926. PubMed ID: 30121265
    [No Abstract]   [Full Text] [Related]  

  • 26. Noninvasive risk stratification of patients with transthyretin amyloidosis.
    Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
    JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of light-chain and transthyretin-related categories in cardiac amyloidosis: A systematic review and meta-analysis.
    Xin Y; Hu W; Chen X; Hu J; Sun Y; Zhao Y
    Hellenic J Cardiol; 2019; 60(6):375-383. PubMed ID: 30742933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.
    Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F
    JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac amyloidosis: pathogenesis, clinical context, diagnosis and management options.
    Alkhawam H; Patel D; Nguyen J; Easaw SM; Al-Sadawi M; Syed U; Zaiem F; Homsi M; Vittorio TJ
    Acta Cardiol; 2017 Aug; 72(4):380-389. PubMed ID: 28705053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive Mapping of the Electrophysiological Substrate in Cardiac Amyloidosis and Its Relationship to Structural Abnormalities.
    Orini M; Graham AJ; Martinez-Naharro A; Andrews CM; de Marvao A; Statton B; Cook SA; O'Regan DP; Hawkins PN; Rudy Y; Fontana M; Lambiase PD
    J Am Heart Assoc; 2019 Sep; 8(18):e012097. PubMed ID: 31496332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left atrial strain imaging differentiates cardiac amyloidosis and hypertensive heart disease.
    Rausch K; Scalia GM; Sato K; Edwards N; Lam AK; Platts DG; Chan J
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):81-90. PubMed ID: 32728989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial perfusion in cardiac amyloidosis.
    Chacko L; Kotecha T; Ioannou A; Patel N; Martinez-Naharro A; Razvi Y; Patel R; Massa P; Venneri L; Brown J; Porcari A; Knott K; Manisty C; Knight D; Lockie T; Rakhit R; Lachmann H; Wechelakar A; Whelan C; Ponticos M; Moon J; González A; Gilbertson J; Riefolo M; Leone O; Xue H; Hawkins P; Kellman P; Gillmore J; Fontana M
    Eur J Heart Fail; 2024 Mar; 26(3):598-609. PubMed ID: 38247182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis.
    Ternacle J; Bodez D; Guellich A; Audureau E; Rappeneau S; Lim P; Radu C; Guendouz S; Couetil JP; Benhaiem N; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Mohty D; Deux JF; Damy T
    JACC Cardiovasc Imaging; 2016 Feb; 9(2):126-38. PubMed ID: 26777222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additional Prognostic Value of 2D Right Ventricular Speckle-Tracking Strain for Prediction of Survival in Heart Failure and Reduced Ejection Fraction: A Comparative Study With Cardiac Magnetic Resonance.
    Houard L; Benaets MB; de Meester de Ravenstein C; Rousseau MF; Ahn SA; Amzulescu MS; Roy C; Slimani A; Vancraeynest D; Pasquet A; Vanoverschelde JJ; Pouleur AC; Gerber BL
    JACC Cardiovasc Imaging; 2019 Dec; 12(12):2373-2385. PubMed ID: 30772232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic Resonance in Transthyretin Cardiac Amyloidosis.
    Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Zumbo G; Knight DS; Kotecha T; Francis R; Hutt DF; Rezk T; Rosmini S; Quarta CC; Whelan CJ; Kellman P; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    J Am Coll Cardiol; 2017 Jul; 70(4):466-477. PubMed ID: 28728692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LGE Provides Incremental Prognostic Information Over Serum Biomarkers in AL Cardiac Amyloidosis.
    Boynton SJ; Geske JB; Dispenzieri A; Syed IS; Hanson TJ; Grogan M; Araoz PA
    JACC Cardiovasc Imaging; 2016 Jun; 9(6):680-6. PubMed ID: 27209101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative Apical Sparing of Myocardial Longitudinal Strain Is Explained by Regional Differences in Total Amyloid Mass Rather Than the Proportion of Amyloid Deposits.
    Bravo PE; Fujikura K; Kijewski MF; Jerosch-Herold M; Jacob S; El-Sady MS; Sticka W; Dubey S; Belanger A; Park MA; Di Carli MF; Kwong RY; Falk RH; Dorbala S
    JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1165-1173. PubMed ID: 30121266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to Image Cardiac Amyloidosis: A Practical Approach.
    Dorbala S; Cuddy S; Falk RH
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1368-1383. PubMed ID: 31607664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Right Ventricular Strain Measured by Two-Dimensional Echocardiography in the Diagnosis of Cardiac Amyloidosis.
    Moñivas Palomero V; Durante-Lopez A; Sanabria MT; Cubero JS; González-Mirelis J; Lopez-Ibor JV; Navarro Rico SM; Krsnik I; Dominguez F; Mingo AM; Hernandez-Perez FJ; Cavero G; Santos SM
    J Am Soc Echocardiogr; 2019 Jul; 32(7):845-853.e1. PubMed ID: 31078369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance.
    Martini N; Aimo A; Barison A; Della Latta D; Vergaro G; Aquaro GD; Ripoli A; Emdin M; Chiappino D
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):84. PubMed ID: 33287829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.